Pyrrolidinium derivatives as antagonists of M3 muscarinic receptors
Details for Australian Patent Application No. 2003233967 (hide)
International Classifications
Event Publications
28 August 2003 Complete Application Filed
Priority application(s): 200200889 16.04.02 ES
4 December 2003 Application Open to Public Inspection
Published as AU-B-2003233967
21 February 2008 Alteration of Name
The name of the applicant has been altered to Almirall AG Amendments
25 September 2008 Assignment before Grant
Almirall AG The application has been assigned to Laboratorios Almirall, S.A.
6 August 2009 Application Accepted
Published as AU-B-2003233967
3 December 2009 Standard Patent Sealed
4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003233968-USE OF BIOLOGICAL PHOTORECEPTORS AS DIRECTLY LIGHTACTIVATED ION CHANNELS
2003233966-ANALOGOUS COMPOUNDS OF STROBILURINES AND THEIR USE AS ACARICIDES AND INSECTICIDES
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser
